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ABSTRACT

A virus having the identifying characteristics of ATCC
VR2396 is disclosed. This virus has the trait of enhanced
polyhedra production stability and resists forming a few
polyhedra mutant virus. A method of protecting crops from
insects comprising applying an insecticidally effective
amount of virus having the identifying characteristics of
ATCC VR2396 is also disclosed.
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METHOD OF PROTECTING PLANTS FROM
INSECTS BY APPLYING GYPSY MOTH
VIRUS WITH ENHANCED POLYHEDRA
PRODUCTION STABILITY

fewer polyhedra (FP mutants).
For gypsy moth virus production to be competItIVe,
means of reducing production costs must be devised. One
approach is the development of insect cell lines that produce
high amounts of polyhedra. Lynn et al., (Appl. Envron.
Microbiol., 55, 1049-1051, 1989) have developed a fatbody cell line that produces greater amounts of polyhedra
than other gypsy moth cell lines.
What is needed in the art of gypsy moth control is an
improved strain of LdNPV capable of enhanced production.

5

This application is a divisional of U.S. Ser. No. 08/290,
634, filed Aug. 15, 1994, now U.S. Pat. No. 5,420,031,
which is a continuation of U.S. Ser. No. 08/015,961, filed
Feb. 8, 1993, now abandoned.
10

FIELD OF THE INVENTION
The general field of the present invention is methods of
controlling plant pests, such as gypsy moths. Specifically,
the field of the present invention is gypsy moth virus strains.

SUMMARY OF THE INVENTION
15

BACKGROUND
Chemical pesticides and fungicides are the most commonly used control agents for forest insect pests and fungal
diseases. In excess of 350 billion pounds of these agents are 20
used annually in the United States to control pests and
diseases in forestry, agriculture, and residential areas. Broad
spectrum insecticides and fungicides have adverse impacts
not only on their target organisms but also on beneficial
insects and fungi and, consequently, on the entire ecosystem. 25
In addition, chemical residues may cause health problems
among the human population.
Interest in biological insect and fungal control agents is
growing as a consequence of concerns regarding chemical 30
pesticide use. A number of bacteria synthesize antifungal
compounds and over 1500 microorganism and microbial
products have been identified that are insecticidal. Generally, natural control agents have little adverse ecological
impact due to their specificity for the target host. Long term 35
environmental hazards and health concerns are not a factor
with biological control agents because chemical residues are
not present. Unfortunately, biological control agents suffer
from several disadvantages in comparison to chemical pesticides, including cost of production, efficacy, and stability. 40
One particularly troublesome plant pest is the gypsy moth
Lymantria dispar. The gypsy moth was first imported from
Europe into North America near Boston in 1869. Since then,
the area of gypsy moth infestation has increased to include
almost the entire New England area, New York, Delaware, 45
Maryland, New Jersey, Pennsylvania, Virginia, West Virginia, Ohio, and Michigan. (McFadden, et al., Forest Insect
Guilds: Patterns of Interaction with Host Trees, Y. N.
Baranchikov, et al. pp. 172-186. US Department of Agriculture, For. Servo Gen. Tech. Rep. NE-1S3, Radnor, Pa., 50
1989.) Several chemical insecticides have been used for
gypsy moth control. DDT is one of the most effective
chemical insecticides used against gypsy moths.
Knowledge of the environmental impacts of DDT and
other chemical insecticides has caused all industry shift to 55
the use of agents such as Dimilin and Bacillus thuringiensis
(Bt) for gypsy moth control. The Lymantria dispar nuclear
polyhedrosis virus (LdNPV), which is pathogenic to Lymantria dispar (gypsy moth), is also used as a biocontrol agent.
LdNPV has the significant advantage over other control 60
agents of specificity for the gypsy moth. Consequently,
LdNPV is the agent of choice for all areas and particularly
for use in environmentally sensitive areas. However, LdNPV
is not used extensively for gypsy moth control because of
high production costs and low efficacy. One particular 65
problem with LdNPV propagation in cell culture is the
propensity of the virus to mutate into a form that produces

The present invention is a virus having the identifying
characteristics of ATCC VR2396. This virus has the trait of
enhanced resistant to mutation to an FP form of LdNPV
virus.
The present invention is also a virus derived from ATCC
VR2396, wherein the virus retains the characteristics of
polyhedra production stability.
The present invention is also a method of protecting
plants from insects, comprising applying to an insect or an
insect habitat an insecticidally effective amount of a virus
having the identifying characteristics of ATCC VR2396. In
a preferred form of the invention, the insects are gypsy
moths.
The present invention is also an insecticidal composition
comprising an insecticidal amount of a virus having the
identifying characteristics of ATCC VR2396 and an inert
carrier.
It is an object of the present invention to control insect
pests.
It is another object of the present invention to provide an
LdNPV virus with enhanced polyhedra production stability.
It is another object of the present invention to provide an
LdNPV virus with enhanced resistance to mutating to an FP
form of LdNPV virus.
It is an advantage of the present invention that insect
control may be provided at lower cost.
It is another advantage of the present invention that ATCC
VR2396 may be propagated with a fewer amount of FP
mutants forming.
Other objects, advantages and features of the present
invention will become apparent after review of the specification, drawings and claims.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. IA is a graphical comparison of the amount of
pol yhedra produced in cells infected with A21-MPV after 14
serial passages versus cells infected with A21-2 after 6 serial
passages in L. dispar 652Y cells; FIG. IB is a tabular form
of the same data.
FIG. 2A is a graphical comparison of the number of cells
found to contain polyhedra after infection with A21-MPV
after 14 serial passages versus the number of cells found to
contain polyhedra after infection with A21-2 after 6 serial
passages in L. dispar 652Y cells; FIG. 2B is a tabular form
of the same data.
FIG. 3A is a graphical comparison of the amount of
budded virus produced by isolates A21-MPV after 14 serial
passages and A21-2 after 6 serial passages in L. dispar cells;
FIG. 3B is a tabular form of the same data.
FIG. 4A demonstrates the retention of wild-type phenotype by A21-MPV through multiple passages; FIG. 4B
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demonstrates the percentage of cells with polyhedra after
infection with A21-MPV during extended serial passage in
L. dispar 652Y cells.
FIG. SA is a graphical comparison of polyhedra per cell
of cells infected with A21-MPV and cells infected with A21
during serial passage; FIG. SB is a tabular form of the same
data.
FIG. 6A is a graphical comparison of the percentage of
polyhedra in cells infected with A21-MPV versus A21
during serial passage; FIG. 6B is a tabular form of the same
data.
FIG. 7A is a graphical comparison of budded virus
produced by isolates A21 and A21-MPV during serial passage in L. dispar 652Y cells; FIG. 7B is a tabular form of the
same data.
FIG. 8 indicates the percentage of A21 plaques exhibiting
the FP phenotype compared to the number of A21-MPV
plaques exhibiting the FP phenotype during serial passages.

and release nucleocapsids which infect the insect midgut
cells, thereby initiating the infection process.
For commercial applications, LdNPV is currently produced in gypsy moth larvae at a cost of approximately
$30.00 for enough polyhedra to treat an acre of forest.
Production is the most expensive component in the commercial use of LdNPV. Virus production is limited by the
efficiency of production of polyhedra in larvae. Efforts to
produce polyhedra in cell culture systems are being made to
generate a more economical production methodology. In
comparison, production costs of Dimilin and Bt are approximately $3.00 per acre equivalent.
However, problems exist in obtaining virus from cell
culture. A class of mutant baculoviruses called few polyhedra (FP) mutants are generated at high frequency during
viral replication in insect cell culture. FP mutants have the
characteristics of producing few polyhedra that contain few
or no viral nucleocapsids and are noninfectious. In addition,
FP mutants produce a greater amount of budded virus
(non-occluded virus) compared to wild type virus.
FP mutants have been generated during serial passage of
the Autographa californica nuclear polyhdrosis virus (AcMNPV), Trichoplusia pi MNPV (TnMNPV), Galleria mellonella MNPV (GmMNPV), and Lymantria dispar MNPY.
Studies on AcMNPV have shown that FP mutants are often
generated through the insertion of host DNA sequences into
the viral genome. The frequency of FP mutant genesis
during viral serial passage is specific to the virus species
being passed. Table I below summarizes the frequency ofFP
mutant formation as a function of serial passage.
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DESCRIPTION OF THE INVENTION
I. Brief Overview
We have identified an LdNPV isolate, derived from
LdNPV isolate A21, that exhibits an enhanced stability of
wildtype polyhedra production levels during passage in L.
dispar 652Y cells. All wild-type LdNPV isolates studied to
date rapidly mutate during serial passage in 652Y cells to
few polyhedra (FP) viral mutants. FP mutants exhibit the
characteristics of production of an average of 4-10 polyhedra per cell, of polyhedra that are virtually devoid of viral
nucleocapsids, and of a greater amount of budded virus
compared to wild-type virus. In contrast, wild-type virus
produce an average of 30--60 polyhedra per cell that contain
many viral nucleocapsids and a lower amount of budded
virus compared to FP mutants.
The unique attribute of our new isolate, A21-MPV, is a
reduced tendency to mutate to an FP mutant during serial
passage. Consequently, during production of LdNPV polyhedra, which requires serial passage, isolate A21-MPV will
produce a far greater number of polyhedra than wildtype
virus. In addition, a greater percentage of 652Y cells
infected with isolate A21-MPV produce polyhedra in comparison to the percentage of cells that produce polyhedra
after infection with wild-type LdNPY.

25

30

TABLE I

40
a.
b.
c.
d.

45

2. In General
Two forms of LdNPV (occluded and non-occluded virus)
are produced during viral replication. (Granados, et al., The
Biology of Baculoviruses, R. R. Granados and B. A. Federici
(eds.) pp. 89-108. CRC Press, Boca Raton, Fla., 1986.)
Early after viral infection, non-occluded virus is produced.
This virus leaves the cell and is responsible for secondary
infections within the hemocoel of the host insect. A different
form of virus is produced late in infection that is occluded
into a protein matrix composed primarily of a viral-encoded
protein. These structures, approximately I to 3 micrometers
in diameter and polyhedral in shape, are termed "polyhedral
occlusion bodies" or "polyhedra". Nucleocapsids within
polyhedra are protected from most environmental conditions
with the exception of ultraviolet light.
Gypsy moth virus is applied through sprayers in the field
in the form of polyhedra, which are ingested by gypsy moth
larvae feeding on tree foliage. Once within the alkaline
environment of the insect midgut, the polyhedra dissolve

Passages Necessary to Accumulate FP
Mutant Percentages of:

35

50

55

60

65

Virus

25%

50%

75%

GrnNMPV'
TnMNPVb
AcMNPVc
LdMNPVd

4.5
4.0
1.0

5.5
5.0
1.5
1.0

7.0
6.0
3.5

>90%
8.0
10.0
>4.0
2.0

Fraser, et al., (1982) VIrology, 117,366-378.
Potter, et al., (1976) J. Virology, 18, 1040-1050.
Hink, et al., (1976) J. Invertebrate Pathology, 27, 49-55.
Slavicek, J. M. Unpublished data

Our approach to increase polyhedra production in cell
culture is the development of a viral strain that exhibits a low
frequency of FP mutant generation and consistently produces polyhedra without reductions as a consequence of
passage. These traits are what we mean by "polyhedra
production stability".
Our preliminary studies with LdNPV polyhedra production in 652Y cells found a reduction in the number of
polyhedra produced as a function of virus passage number.
When non-occluded virus is obtained from fourth-instar
gypsy moth larvae (that were infected per os with polyhedra)
and used to infect 652Y cells, the infected cells produce
approximately 50 polyhedra per cell (Table 2). After five
passages in cell culture, the number of polyhedra produced
per cell decreased to approximately 6. The cost of cell
culture production could be reduced if the initial high level
of polyhedra formation could be stabilized.
We have identified a viral variant (termed A21-MPV,
which stands for Many Polyhedra Variant) that maintains a
high level of polyhedra synthesis after repeated passage in
cell culture (Table 2). 652Y cells infected with MPV contain
approximately 45 polyhedra per cell. In addition, more of
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the infected cells produce polyhedra in comparison to wild
type isolate A21. Virus A21-MPV has been deposited with
the American Type Culture Collection, Rockville, Md., on
Dec. 16, 1992 at Accession Number VR2396 under the
conditions of the Budapest Treaty. Deposit of this sample
does not imply or grant a license to use the virus.

infected with isolate A21, due to the large number of
polyhedra present. The majority of infected cells, greater
than 99.99%, contained from 4 to 10 polyhedra, which is
characteristic of FP viral mutants. The virus that infected the
cells containing a large number of polyhedra was purified
and termed LdNPV isolate A21-MPV (many polyhedra
variant, MPV). Isolate A21-MPV was serially passed in cell
culture for 20 passages. The number of 652Y cells used for
each passage were 1x104, 1x105, 1x106 , and 5x106 for
passages 1-8,9-10, 11 and 12-20, respectively.
To generate cell culture lines of LdNPV isolates A21,
B21, 163, and 122, budded virus was obtained from L.
dispar larvae infected with these isolates and used to infect
652Y cells in culture. Budded virus from these initial
infections was used to generate the plaque purified viral
lines A21-2, B21-1, 122-2, and 163-2. After plaque purification the isolates were serially passed in cell culture for 6
passages. The number of 652Y cells infected at each passage
were 1x104, 1x105, lx106, and 5x106 for passages 1, 2, 3
and 4-6, respectively.

5

TABLE 2

Isolate

1st passage
polyhedra
production

Polyhedra
production per
cell after more
than 5 passages

A21
A21·MPV

52
58

45

6

Percentage of
cells containing
polyhedra

10

51
85
15

3. A21-MPV Isolation
LdNPV isolates A21, B21, 122, and 163 were purified to
genotypic homogeneity by low dose infection of L. dispar 20
larvae. Fourth instar larvae were fed diet containing a dose
of LdNPV that caused approximately 4 to 10% mortality.
Polyhedra were collected from individual cadavers, and
used for a second round of low dose infections. Polyhedra
were collected from individual cadavers, viral genomic 25
DNA was isolated and analyzed to assess the degree of
genotypic heterogeneity present. Isolates A21, B21,163 and
122 appeared to be genotypically homogenous and were
used for further investigations.
30
The initial purpose of the experiment during which we
isolated A21-MPV was to develop the methodology for
generation of recombinant viruses. LdMNPV isolate A21
and a transplacement plasmid pLd-B-Gal that contains the
beta galactosidase gene from E. coli were examined in this 35
study.
Lymantna dispar 652Y cells were propagated in a modified insect cell culture medium, such as "GOODWIN'S
IPL-52B" (JRH Biosciences) medium with 10% heat-inactivated fetal bovine serum and 6.25 roM glutamine. 2x105 40
cells were plated per well in P6 plates (Coming) prior to
transfection. Media was removed and replaced with 1.5 ml
serum free media, and 100 ul of lipofection solution (50 ul
10 roM Tris, 1 roM EDTA, pH 7.5; 2 ug, 5 ug, and 10 ug of
LdMNPV DNA, and 4 ug, 2 ug, and 4 ug of pLd-B-Gal 45
DNA for trials A, B, and C, respectively; and 50 ul of a
transfection reagent, such as "LIPOFECTIN" reagent,
Gibco BRL) was added to the P6 wells. After a 4 hour
incubation period the media was replaced with complete
media containing 50 ug/ml gentamicin. Fifteen days after 50
transfection the cells were harvested and used for enzymatic
B-galactosidase assays to detect the presence of recombinant
LdMNPV containing the B-galactosidase gene. The percentage of recombinant virus present was calculated after determination of recombinant virus titer by plaque assay (using 55
agarose containing a substrate for the enzyme ~-galaxctosi
dase, such as "BLDO GAL" supplied by Gibco) and the total
virus titer by TCID-50 Assay.
LdMNPV isolate A21-MPV was identified in this study.
However, A21-MPV does not contain the beta-galactosidase 60
gene. Isolate A21-MPV is a mutant derivative of isolate A21
that was detected during the course of the study described
above. The genesis of A21-MPV is not related to the
experimental manipulations used to generate a recombinant
virus. Cells containing isolate A21-MPV were recognized 65
through examination of infected cells by light microscopy.
These cells were black in color, in contrast to all other cells

4. Restriction endonuclease analysis of isolate
A21-MPV.
A21 and A21-MPV genomes were subject to restriction
endonuclease digestion with BglII, EcoRI, EcoRV, HindIII,
BarnHI, and PstI, and the digestion profiles were compared
to determine whether DNA restriction fragment length polymorphisms existed between the viruses. No differences in
DNA fragment lengths were detected. This finding supports
the hypothesis that isolate A21-MPV is a mutant derivative
of isolate A21. The approach used in this comparison will
detect DNA insertions or deletions of approximately 0.5 kb
or greater in length, and nucleotide additions, deletions or
alterations of the restriction endonuclease recognition sites
of the enzymes used.
5. Bioassay data on isolate A21-MPV, A21, and
Gypchek (a standard gypsy moth virus).
Comparative bioassays were performed as described in
Slavicek et al., (1992, 1. Invertebrate Pathology 59:
142-148). Briefly, polyhedra pastes of the various isolates
were suspended in 10 ml of Sterile 0.05M Tris-HCI buffer,
pH 7.2, and briefly sonicated to disperse the polyhedra. A
100-mg lyophilized sample of standard gypsy moth virus,
such as Gypchek, was similarly suspended and vigorously
ground in a glass tissue homogenizer for 3 min. Five serial
lO-fold dilutions of each of the stock virus suspensions were
prepared in Tris buffer. Dilutions were prepared such that
final polyhedra concentrations in diet fed to test insects
ranged between 1x102 and 1x107/ml. One milliliter of
dilution was added to 99 ml of tempered (52 0 C.) diet and
vigorously mixed with a variable-speed stirrer (5000 rpm)
for 30 sec. Virus-treated diet was cooled and cooled and cut
into 1.25-cm3 cubes.
Each virus dosage was presented to five groups of 10
newly molted second instar larvae from a standard laboratory strain of the gypsy moth (New Jersey, F34). Each group
of 10 larvae was confined to a 100x15-mm plastic petri dish
and given two 1.25-cm3 virus-treated diet cubes on which to
feed for 48 hr. Larvae were given untreated diet ad libitum
for the remaining 12 days of the bioassay. Five groups of 10
larvae (controls) were fed untreated diet for 14 days. Larvae
were reared in a growth chamber at 24±2° under a 16/8-hr
light/dark photoperiod and observed daily for mortality.
Dead larvae were removed and examined microscopically to
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confirm MPV deaths.
Mortality data were examined by Probit analysis using a
statistical software program, such as "POLO-PC" (LeOra
Software, Berkeley, Calif.). Potencies of isolates A2I-MPV
and A21 relative to standard Gypchek were estimated by
comparing LC so values.
Gypchek is the name of the LdMNPV registered by the
Forest Service and is used currently for gypsy moth control.
Gypchek is available from U.S. Forest Service, Northeastern
Forest Experiment Station, Hamden, Conn.
The results of the bioassay are tabulated in Table 3.

5

10

TABLE 3
Isolate
Gypchek
A2l
A2l-MPV

LC-50"

Limitsb

LC-90"

Limits

3800
4700
5000

2500-6000
2800-7800
3400-7600

24,000
32,000
39,000

14,000-56,000
17,000-82,000
23,000-86,000

15

". LC-50 and LC-90 (lethal concentration) values are the number of polyhedra 20
fer ~. of diet that cause 50% and 90% larval mortality, respectively.
. Llllut values are numbers of polyhedra per ml of diet that cause 50% and
90% larvae mortality, respectively.

The minor differences found in LC-50 and LC-90 values
exhibited by isolates A2I, A2I-MPV and Gypchek were not
significant. This finding indicates that the biological activity
of A21-MPV is essentially the same as Gypchek, and
consequently A2I-MPV could be used for control of the
gypsy moth.

25

propylene oxide.
The samples were infiltrated over a 24-hr period with
propylene oxide: "PolylBed 812" (25.55 g "Poly Bed", 13.5
g dodecenylsuccinic anhydride, 10.9 g nadic methylanhydride, Polysciences) at 2:1, 1:1, and 1:2 ratios. After infiltration, the polyethylene capsules were flushed with freon
and filled with plastic embedding medium, such as "POLY!
BED 812 containing 2% DMP 30 (Polysciences), incubated
at 35° C. for approximately 15 hr, 45° C. for 8 hr and finally
at 60° C. overnight. The samples were sectioned with a
microtonme, such as a diamond knife on a Reichert-]ung
"ULTRACUT E43", the sections stained for 20 min in 5%
uranyl acetate in methanol, poststained in lead nitrate (2.7%
lead citrate, 3.5% sodium citrate, 0.I6N NaOH), and viewed
with a Hitachi model HU l1E-I transmission electron
microscope. Polyhedra cross sections were photographed,
and the number of virions present within cross-sections were
quantified by counting.
In the A21 samples, numerous viral nucleocapsids are
evident in cross-sections produced at the first passage. In
contrast, cross-sections of polyhedra produced at the fifth
passage contain few or no viral nucleocapsids. In the A2IMPV sample, numerous viral nucleocapsids are evident in
cross-sections produced at both the first passage and fifth
passage. The presence of numerous viral nucleocapsids in
polyhedra produced at the fifth passage by A21-MPV indicates that this isolate is producing normal polyhedra at this
passage, in contrast to isolate A21.

30

7. Comparison of Polyhedra Production Attributes
of Isolates A2I-MPV and A21-2 After Plaque
Purification in Cell Culture

6. Microscopy Comparison
Comparison of L. dispar 652Y cells infected with LdMNPV isolates A21-2 and A21-MPV via light microscopy
demonstrates the difference in polyhedra production and,
thus, the biological difference between the two viruses.
652Y cells were infected with 0.2 TCID-50 units per cell of
A21-2 and A2I-MPY. Seven days after infection the cells
were examined by light microscopy and photographed at
lOOX magnification. The cells infected with isolate A21-2
contain very few polyhedra. In contrast, cells infected with
A2I-MPV contain a large number of polyhedra and appear
black at this magnification level.
Electron micrographs of polyhedra cross-sections produced by isolate A21 and A2I-MPV infection at passage 1
and passage 5 can also differentiate between the two strains.
652Y cells were infected with 0.2 TCID-50 units per cell of
either A21 or A2I-MPV. Seven days after infection polyhedra were harvested and prepared for examination by electron
microscopy.
To prepare for electron microscopy, polyhedra were fixed
in sodium cacodylate buffer, pH 7.2 (0.05M sodium cacodylate, 0.5 mM HCI), containing 1% glutaraldehyde at 4° C.
for 20 min. Polyhedra were then fixed in sodium cacodylate
buffer with 3% glutaraldehyde for 1 hr at 4° C. The samples
were washed 3X in sodium cacodylate buffer over a I-hr
period. The samples were postfixed in sodium cacodylate
buffer containing 2% osmium tetroxide for 2.5 hr at ambient
temperature and then washed 3X in sodium cacodylate
buffer over a I-hr period. Molten agar was added to the
samples (final concentration 2%) and allowed to gel. The
samples then were cut into I_mm2 blocks and incubated
overnight in 35% ethanol. The samples were dehydrated
through incubation in an ethanol series (35, 50, and 70%
with 2% uranyl acetate, 85, 95, IOO%-3X) for 5-7 min at
each step, except for the 70% step which was for 1 hr. The
samples were then washed 3X (10 min each wash) in

35

40

45

50

55

60

65

The number of polyhedra produced per cell within cells
containing polyhedra, the percentage of cells with polyhedra, and the amount of budded virus produced by isolates
A2I-MPV after 14 passages in cell culture and isolateA21-2
after 6 passages in cell culture were determined and compared. The number of polyhedra per cell produced by
isolates A2I-MPV and A21-2 was determined 3, 5, and 7
days post infection (p.i.). On all days p.i. examined, cells
infected with isolate A2I-MPV contained significantly more
polyhedra per cell within cells containing polyhedra compared to cells infected with isolate A21-2 (FIG. 1). At seven
days p.i. cells infected withA2I-MPV contained an average
of 46.4 polyhedra, in contrast to 5.2 polyhedra per cell in
cells infected with A21-2.
The percentage of cells containing polyhedra was determined 3, 5, and 7 days p.i. A significantly greater percentage
of cells were found to contain polyhedra at 3, 5, infected
with A21-2 (FIG. 2). At 7 days p.i. an average of 85.7% of
cells infected with A2I-MPV contained polyhedra. In contrast, 64.3% of cells infected with A21-2 contained polyhedra 7 days p.i.
The amount of budded virus produced by isolates A21MPV and A21-2 was determined 1,3,5, and 7 days p.i. On
days 3, 5, and 7 p.i., A21-2 produced a greater amount of
budded virus in comparison to A2I-MPV (FIG. 3). On days
5 and 7 p.i. A21-2 produced significantly more budded virus
than A2I-MPV.
These results demonstrate that isolate A2I-2 exhibits the
attributes of an FP mutant at the 6th passage in cell culture.
In contrast, A2I-MPV has retained a wild-type polyhedra
production phenotype through the 14th serial passage. A2IMPV was then serially passed an additional 6 times through
passage 20. As shown in FIG. 4, A21-MPV retained a
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wild-type phenotype through the 20th passage. These results
demonstrate the enhanced stability of polyhedra production
exhibited by A21-MPV.
Isolates B21-1, 122-2 and 163-2 were serially passed in
652Y cells for 6 passages as described for isolate A21-2.
Similarly to A21-2 isolates B2l-1, 122-2, and 163-2 exhibited the attributes of FP mutants at the 6th passage. This
result demonstrates the high frequency of FP mutants at the
6th passage and demonstrates the high frequency of FP
mutant formation with wild-type strains of LdNPV in contrast to isolate A21-MPV

5

10

8. Polyhedra Production Characteristics During
Serial Passage
15

To further determine the stability of polyhedra production
by A21-MPV and determine the number of passages necessary for a wild-type virus to mutate to an FP mutant,
polyhedra production by isolates A21 and A21-MPV were
examined through five passages in cell culture. Viral nucleocapsid occlusion characteristics of A21 and A21-MPV during serial passage are related below in Table 4. LdMNPV
isolates A21 and A21-MPV were serially passed five times
in L. dispar 652Y. L. dispar larvae were infected per os with
A21 (non-plaque purified) polyhedra produced in larvae and
A21-MPV polyhedra produced in cell culture. Five days
after infection larvae were bled, and the hemolymph was
used to infect 1x1Q6 L. dispar 652Y cells at 0.2 TCID/50
units per cell. This first infection in cell culture was passage
number 1. Budded virus from this infection was then used to
infect new cells to generate passage 2. The remaining
passages examined in this study, passages 3-5, were generated using budded virus from the previous passage as
inoculum.
Polyhedra produced by these isolates after each passage
were prepared for examination by electron microscopy as
described above. The number of viral nucleocapsids present
in polyhedra cross sections were determined, and are presented below in terms of the number of nucleocapsids
present per square micrometer of cross section surface area
(Table 4).
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9. Viral formulation and application for gypsy moth
control

TABLE 4
Number of viral nucleocapsids per urn2 of cross section area
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Passage
I

Passage
2

Passage
3

Passage

Passage

Isolate

4

5

A21
A21-MPV

5.7
5.2

4.0
2.9

2.5
5.7

1.1
6.1

0.5
3.1
50

The number of viral nucleocapsids present in polyhedra
produced by A21 decreased during serial passage from an
average of 5.7 at passage 1 to 0.5 at passage 5. In contrast,
the number of nucleocapsids present in polyhedra produced
by isolate A21-MPV remained essentially constant during
five serial passages.
L. dispar 652Y cells exhibited essentially the same number of polyhedra per cell at the first passage infection with
isolates A21-MPV andA21 (FIG. 5). In contrast, at passages
two through five, cells infected with A21-MPV contained
significantly more polyhedra per cell compared to cells
infected with A21 (FIG. 5). After five serial passages, cells
infected with A21-MPV contained an average of 35.4 polyhedra. In contrast, cells infected with A21 contained an
average of only 6.4 polyhedra per cell. After each serial
passage, cells infected with A21 contained significantly

fewer polyhedra in comparison to the previous passage. In
contrast, no significant difference was found in the number
of polyhedra per cell after infection with A21-MPV during
five serial passages.
At the first passage, cells infected with A21-MPV and
A21 exhibited the same percentage of cells containing
polyhedra. At passages two through five a significantly
greater percentage of cells infected with A21-MPV contained polyhedra in comparison to cells infected with A21.
At passage five, 84.0% of cells infected with A2l-MPV
contained polyhedra whereas only 51.2% of cells infected
with A21 contained polyhedra. In addition, A21-MPV
exhibited a significant increase in the percentage of cells
containing polyhedra after the first passage. In contrast, A21
exhibited a significant reduction in the percentage of cells
containing polyhedra after the first passage. FIG. 6 graphically displays these results.
Isolate A21-MPV exhibited stable budded virus production during five serial passages. The amount of budded virus
produced by A21-MPV was less than the amount of budded
virus produced by A21 at passages 2-5. This difference was
found to be significant at passages 2, 4, and 5, and nearly
significant at passage 3. In addition, A21 exhibited an
increase in budded virus production after the first passage.
FIG. 7 graphically displays these results.
The percentage of A21-MPV and A21 viruses exhibiting
the FP or MP phenotype was determined during serial
passage. Budded virus produced at each serial passage was
used to generate viral plaques. Ninety-six plaques of each
isolate after each passage were used to infect L. dispar 652Y
cells, and the infections were scored as exhibiting either the
MP or FP phenotype. Budded virus obtained from insect
hemolymph was used for passage zero for both viral isolates.
As shown in FIG. 8, the percentage of A21 plaques exhibiting the FP phenotype rapidly increased during serial passage from zero to 82% after just two serial passages. In
contrast, A21-MPV maintained the MP phenotype during
cell passage.
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We envision that the A21-MPV isolate may be applied to
insects or insect habitats in a manner similar as that currently
used for LdMNPV The virus must be ingested by the insect
to be effective. However, insects may also become infected
as a consequence of ingestion of virus present on the insect
or on insect egg masses. Therefore, in the case of plants, the
virus will typically be applied to leaf surfaces.
LdMNPV has been formulated as described below for
gypsy moth control:
10 g Gypchek (5.0xlQlO polyhedra per gram)
227 g (6% wtlvol) a UV light screen, such as "ORZAN
LS" ITT Raynonier, Seattle, Wash.)
0.47 liters (12.5% by vol) a liquid supplement consisting
offeed stock molasses, such as "PRO MO", (Southern
States Cooperative, Richmond, Va.)
77.6 rnl (2% by vol) a sticker-spreader, such as "RHOPLEX B60A" Rohm & Haas Company, Philadelphia,
Pa.) 3.24 liters (85.5% by vol) water
A similar preparation is envisioned for the A21-MPV
isolate.
The amount of virus to be administered to the insect or the
insect habitat is an amount effective to reduce insect infestation as predetermined by routine testing. If the ultimate
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response is insect mortality, an "insecticidally effective
amount" is defined to be those qualities of virus which will
result in a significant mortality rate of a test group, as
compared to an untreated group. The insecticidally effective
amount may vary with the species of pest, stage of larval 5
development, nature of the substrate, the type of vehicle or
carrier, the period of treatment and other factors.
It is often advantageous to apply viral inoculants with a
carrier. Suitable agronomically acceptable carriers are
known in the art. Inert solids, such as cellulose or sugars, 10
wetable powders, and aqueous surfactant mixtures are illustrative of suitable chemical carriers. Depending on many
factors, the concentration of virus in the final composition
may vary, but would include an insecticidally effective
amount which may typically be between lxl08 to lxl0 11 15
polyhedra per liter, but the preferred embodiment would be
between lx10 10 to lxlO ll polyhedra per liter.
Aerial application of Gypchek has been as follows: An
airplane, such as 448 kW (600 hp) Grumman "AGCAT" .

12
airplane equipped with 8 atomizers, such as "AU 5000"
atomizers manufactured by Micronair can be used for LdNMPV application. Delivery of formulated virus could be
from 1.0xlO ll to 5.0xlOll polyhedra in 7.5 liters per acre at
an airspeed of 160 kmIh. (Podgwaite, et al., J. Economic
Entomology, 85: 1136-1139).
We claim:
1. A method for protecting plants from insects against
which LdMNPV is toxic, said method comprising applying
to such insects or insect habitat an insecticidally effective
amount of a virus designated ATCC VR2396 deposited at the
American Type Culture Collection.
2. A method according to claim 1, wherein said insects are
gypsy moths.
3. A method according to claim 2 wherein said insecticidally effective amount is an amount sufficient to achieve
the desired level of plant protection.
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